Clearly, the in vitro model of AP with MALAT1 overexpression showed the increased expression of IL-6 and TNF-α levels (p < 0.01), while silencing MALAT1 decreased the IL-6 and TNF-α levels (Figure 4(c), p < 0.05). The gene discussed is MALAT1; the disease is alkaline phosphatase measurement.